
AGMI is an AI-native consultancy specializing in life sciences, biopharma, biotech, and healthcare sectors. The firm combines deep domain expertise with advanced AI capabilities to help clients tackle complex challenges such as R&D portfolio strategy, go-to-market planning, scientific due diligence, digital transformation, and operational excellence. AGMI supports businesses in global market expansion, strategic licensing, fundraising, and due diligence, partnering with companies valued over $10 billion. Their services include pricing and reimbursement strategy, customer-centric engagement, launch planning, equity story development, and AI-driven digital transformation, positioning them as a strategic partner for innovation and growth in highly regulated, technical industries.

AGMI is an AI-native consultancy specializing in life sciences, biopharma, biotech, and healthcare sectors. The firm combines deep domain expertise with advanced AI capabilities to help clients tackle complex challenges such as R&D portfolio strategy, go-to-market planning, scientific due diligence, digital transformation, and operational excellence. AGMI supports businesses in global market expansion, strategic licensing, fundraising, and due diligence, partnering with companies valued over $10 billion. Their services include pricing and reimbursement strategy, customer-centric engagement, launch planning, equity story development, and AI-driven digital transformation, positioning them as a strategic partner for innovation and growth in highly regulated, technical industries.